Immune System News and Research

RSS

Rogue killer T cells associated with leukemia drive autoimmune diseases

Gene variants associated with leukemia can produce 'rogue' immune cells that drive autoimmune diseases, according to a new study from the Garvan Institute of Medical Research.

28 Nov 2022

Scientists unravel how bats harbor many viruses without developing symptoms

Bats are asymptomatic carriers of a multitude of viruses that are pathogenic to most other mammals. How has their immune system evolved to shield them from these pathogens?

28 Nov 2022

Are nasal-spray vaccines the solution to respiratory infectious diseases?

A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory illnesses.

28 Nov 2022

Researchers discover a new function of CRISPR/Cas9 gene scissors

For several years now, the CRISPR/Cas9 gene scissors have been causing a sensation in science and medicine.

25 Nov 2022

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.

24 Nov 2022

Study provides a key link between the social environment and healthy brains

As people age, maintaining a positive and predictable social environment becomes more and more important. For instance, keeping close ties with friends and family has been identified as one of the key ingredients to healthy aging.

24 Nov 2022

AI helps design synthetic DNA that controls cells' protein production

With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells' protein production.

24 Nov 2022

Study finds first direct evidence of AMR bacteria migrating from the gut to the lungs

A new study released today in Nature Communications from the Department of Biology, University of Oxford has found the first direct evidence of antibiotic-resistant bacteria migrating from a patient's gut microbiome to the lungs.

24 Nov 2022

New study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

23 Nov 2022

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

James Smyth, associate professor at the Fralin Biomedical Research Institute at VTC, has been awarded a five-year, $2.7 million grant from the National Institutes of Health to discover why viruses that normally infect our lungs can turn deadly when they infect the heart.

23 Nov 2022

MYC proteins form hollow spheres that shield the genome of cancer cells

MYC genes and their proteins play a central role in the emergence and development of almost all cancers. They drive the uncontrolled growth and altered metabolism of tumour cells. And they help tumours hide from the immune system.

23 Nov 2022

Severe COVID-19 associated with an imbalance in key immune system signaling pathway

Researchers at the University of São Paulo in Brazil have found that severe COVID-19 is associated with an imbalance in an important immune system signaling pathway.

23 Nov 2022

Single drug compound may offer a promising new strategy for treating prostate cancer patients

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

23 Nov 2022

CAR T therapy extends its reach beyond oncology

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers.

23 Nov 2022

Scientists move a step closer to advancing personalized cancer treatment

In a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.

22 Nov 2022

New EULAR recommendations for screening and treating infections in AIIRD patients

It is already known that people who are immunocompromised are more prone to infections. Chronic and opportunistic infections are often found in people with an AIIRD, and may be linked to some of the immunosuppressive and immunomodulatory treatments used to treat these rheumatic diseases.

22 Nov 2022

Unexpected declines in cognitive performance after epilepsy surgery

In severe epilepsies, surgical intervention is often the only remedy - usually with great success. While neuropsychological performance can recover in the long term after successful surgery, on rare occasions, unexpected declines in cognitive performance occur.

22 Nov 2022

Survey: Two-thirds of European dietitians believe drinking coffee in moderation has clear health benefits

A new report by the European Federation of the Associations of Dietitians, supported by the Institute for Scientific Information on Coffee, has revealed that almost two-thirds (62%) of European dietitians believe drinking coffee in moderation has clear health benefits, with 86% agreeing that regular moderate intake can improve alertness and 69% agreeing that regular, moderate intake is associated with an improvement in overall sports performance.

22 Nov 2022

Beetroot juice appears to affect gut microbiome, positively impacting intestinal and systemic health

In a recent study published in the Food Chemistry journal, researchers investigated the impact of consuming red beetroot juice for two weeks on gut microbiota.

21 Nov 2022

NIAID awards more than $12 million for the development of antiviral therapies

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

21 Nov 2022

Immune System News and Research

Rogue killer T cells associated with leukemia drive autoimmune diseases

Scientists unravel how bats harbor many viruses without developing symptoms

Are nasal-spray vaccines the solution to respiratory infectious diseases?

Researchers discover a new function of CRISPR/Cas9 gene scissors

Novel cancer-fighting nanoparticles co-deliver a chemotherapy drug and immunotherapy

Study provides a key link between the social environment and healthy brains

AI helps design synthetic DNA that controls cells' protein production

Study finds first direct evidence of AMR bacteria migrating from the gut to the lungs

New study points to a strategy for inhibiting hyper-progression of melanoma

VTC scientist wins $2.7 million to investigate viral infection of the heart that can cause sudden death

MYC proteins form hollow spheres that shield the genome of cancer cells

Severe COVID-19 associated with an imbalance in key immune system signaling pathway

Single drug compound may offer a promising new strategy for treating prostate cancer patients

CAR T therapy extends its reach beyond oncology

Scientists move a step closer to advancing personalized cancer treatment

New EULAR recommendations for screening and treating infections in AIIRD patients

Unexpected declines in cognitive performance after epilepsy surgery

Survey: Two-thirds of European dietitians believe drinking coffee in moderation has clear health benefits

Beetroot juice appears to affect gut microbiome, positively impacting intestinal and systemic health

NIAID awards more than $12 million for the development of antiviral therapies

Immunology eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News